Global Structural Heart Occlusion Devices Market Growth 2026-2032

June 2026 | 96 pages | ID: GAB9D555C9A7EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Structural Heart Occlusion Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Structural heart occlusion devices are specialized medical tools designed to treat various structural heart diseases by closing abnormal openings or defects in the heart. These devices enable minimally invasive procedures, which offer significant benefits over traditional open-heart surgeries.

United States market for Structural Heart Occlusion Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Structural Heart Occlusion Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Structural Heart Occlusion Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Structural Heart Occlusion Devices players cover Abbott, Medtronic, Boston Scientific, MicroPort, Shenzhen Salubris Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Structural Heart Occlusion Devices Industry Forecast? looks at past sales and reviews total world Structural Heart Occlusion Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Structural Heart Occlusion Devices sales for 2026 through 2032. With Structural Heart Occlusion Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Structural Heart Occlusion Devices industry.

This Insight Report provides a comprehensive analysis of the global Structural Heart Occlusion Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Structural Heart Occlusion Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Structural Heart Occlusion Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Structural Heart Occlusion Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Structural Heart Occlusion Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Structural Heart Occlusion Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Patent Ductus Arteriosis (PDA) Occluder
  • Atrial Septal Defects (ASD) Occluder
  • Ventricular Septal Defects (VSD) Occluder
  • Left Atrial Appendage ?LAA? Occluder
  • Patent Foramen Ovale (PFO) Occluder
Segmentation by Application:
  • Congenital Heart Disease
  • Cardioembolic Stroke
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Abbott
  • Medtronic
  • Boston Scientific
  • MicroPort
  • Shenzhen Salubris Pharmaceuticals
  • LifeTech
  • Lepu Scientech Medical
  • Beijing Balance Medical
  • Bluesail Medical
  • Shanghai HeartCare Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Structural Heart Occlusion Devices market?
What factors are driving Structural Heart Occlusion Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Structural Heart Occlusion Devices market opportunities vary by end market size?
How does Structural Heart Occlusion Devices break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Structural Heart Occlusion Devices Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Structural Heart Occlusion Devices by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Structural Heart Occlusion Devices by Country/Region, 2021, 2025 & 2032
2.2 Structural Heart Occlusion Devices Segment by Type
  2.2.1 Patent Ductus Arteriosis (PDA) Occluder
  2.2.2 Atrial Septal Defects (ASD) Occluder
  2.2.3 Ventricular Septal Defects (VSD) Occluder
  2.2.4 Left Atrial Appendage ?LAA? Occluder
  2.2.5 Patent Foramen Ovale (PFO) Occluder
  2.2.6 Structural Heart Occlusion Devices Sales by Type
    2.2.6.1 Global Structural Heart Occlusion Devices Sales Market Share by Type (2021-2026)
    2.2.6.2 Global Structural Heart Occlusion Devices Revenue and Market Share by Type (2021-2026)
    2.2.6.3 Global Structural Heart Occlusion Devices Sale Price by Type (2021-2026)
2.3 Structural Heart Occlusion Devices Segment by Application
  2.3.1 Congenital Heart Disease
  2.3.2 Cardioembolic Stroke
  2.3.3 Structural Heart Occlusion Devices Sales by Application
    2.3.3.1 Global Structural Heart Occlusion Devices Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Structural Heart Occlusion Devices Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Structural Heart Occlusion Devices Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Structural Heart Occlusion Devices Breakdown Data by Company
  3.1.1 Global Structural Heart Occlusion Devices Annual Sales by Company (2021-2026)
  3.1.2 Global Structural Heart Occlusion Devices Sales Market Share by Company (2021-2026)
3.2 Global Structural Heart Occlusion Devices Annual Revenue by Company (2021-2026)
  3.2.1 Global Structural Heart Occlusion Devices Revenue by Company (2021-2026)
  3.2.2 Global Structural Heart Occlusion Devices Revenue Market Share by Company (2021-2026)
3.3 Global Structural Heart Occlusion Devices Sale Price by Company
3.4 Key Manufacturers Structural Heart Occlusion Devices Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Structural Heart Occlusion Devices Product Location Distribution
  3.4.2 Players Structural Heart Occlusion Devices Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR STRUCTURAL HEART OCCLUSION DEVICES BY GEOGRAPHIC REGION

4.1 World Historic Structural Heart Occlusion Devices Market Size by Geographic Region (2021-2026)
  4.1.1 Global Structural Heart Occlusion Devices Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Structural Heart Occlusion Devices Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Structural Heart Occlusion Devices Market Size by Country/Region (2021-2026)
  4.2.1 Global Structural Heart Occlusion Devices Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Structural Heart Occlusion Devices Annual Revenue by Country/Region (2021-2026)
4.3 Americas Structural Heart Occlusion Devices Sales Growth
4.4 APAC Structural Heart Occlusion Devices Sales Growth
4.5 Europe Structural Heart Occlusion Devices Sales Growth
4.6 Middle East & Africa Structural Heart Occlusion Devices Sales Growth

5 AMERICAS

5.1 Americas Structural Heart Occlusion Devices Sales by Country
  5.1.1 Americas Structural Heart Occlusion Devices Sales by Country (2021-2026)
  5.1.2 Americas Structural Heart Occlusion Devices Revenue by Country (2021-2026)
5.2 Americas Structural Heart Occlusion Devices Sales by Type (2021-2026)
5.3 Americas Structural Heart Occlusion Devices Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Structural Heart Occlusion Devices Sales by Region
  6.1.1 APAC Structural Heart Occlusion Devices Sales by Region (2021-2026)
  6.1.2 APAC Structural Heart Occlusion Devices Revenue by Region (2021-2026)
6.2 APAC Structural Heart Occlusion Devices Sales by Type (2021-2026)
6.3 APAC Structural Heart Occlusion Devices Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Structural Heart Occlusion Devices by Country
  7.1.1 Europe Structural Heart Occlusion Devices Sales by Country (2021-2026)
  7.1.2 Europe Structural Heart Occlusion Devices Revenue by Country (2021-2026)
7.2 Europe Structural Heart Occlusion Devices Sales by Type (2021-2026)
7.3 Europe Structural Heart Occlusion Devices Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Structural Heart Occlusion Devices by Country
  8.1.1 Middle East & Africa Structural Heart Occlusion Devices Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Structural Heart Occlusion Devices Revenue by Country (2021-2026)
8.2 Middle East & Africa Structural Heart Occlusion Devices Sales by Type (2021-2026)
8.3 Middle East & Africa Structural Heart Occlusion Devices Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Structural Heart Occlusion Devices
10.3 Manufacturing Process Analysis of Structural Heart Occlusion Devices
10.4 Industry Chain Structure of Structural Heart Occlusion Devices

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Structural Heart Occlusion Devices Distributors
11.3 Structural Heart Occlusion Devices Customer

12 WORLD FORECAST REVIEW FOR STRUCTURAL HEART OCCLUSION DEVICES BY GEOGRAPHIC REGION

12.1 Global Structural Heart Occlusion Devices Market Size Forecast by Region
  12.1.1 Global Structural Heart Occlusion Devices Forecast by Region (2027-2032)
  12.1.2 Global Structural Heart Occlusion Devices Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Structural Heart Occlusion Devices Forecast by Type (2027-2032)
12.7 Global Structural Heart Occlusion Devices Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Abbott
  13.1.1 Abbott Company Information
  13.1.2 Abbott Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.1.3 Abbott Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Abbott Main Business Overview
  13.1.5 Abbott Latest Developments
13.2 Medtronic
  13.2.1 Medtronic Company Information
  13.2.2 Medtronic Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.2.3 Medtronic Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Medtronic Main Business Overview
  13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
  13.3.1 Boston Scientific Company Information
  13.3.2 Boston Scientific Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.3.3 Boston Scientific Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Boston Scientific Main Business Overview
  13.3.5 Boston Scientific Latest Developments
13.4 MicroPort
  13.4.1 MicroPort Company Information
  13.4.2 MicroPort Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.4.3 MicroPort Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 MicroPort Main Business Overview
  13.4.5 MicroPort Latest Developments
13.5 Shenzhen Salubris Pharmaceuticals
  13.5.1 Shenzhen Salubris Pharmaceuticals Company Information
  13.5.2 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.5.3 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Shenzhen Salubris Pharmaceuticals Main Business Overview
  13.5.5 Shenzhen Salubris Pharmaceuticals Latest Developments
13.6 LifeTech
  13.6.1 LifeTech Company Information
  13.6.2 LifeTech Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.6.3 LifeTech Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 LifeTech Main Business Overview
  13.6.5 LifeTech Latest Developments
13.7 Lepu Scientech Medical
  13.7.1 Lepu Scientech Medical Company Information
  13.7.2 Lepu Scientech Medical Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.7.3 Lepu Scientech Medical Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Lepu Scientech Medical Main Business Overview
  13.7.5 Lepu Scientech Medical Latest Developments
13.8 Beijing Balance Medical
  13.8.1 Beijing Balance Medical Company Information
  13.8.2 Beijing Balance Medical Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.8.3 Beijing Balance Medical Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Beijing Balance Medical Main Business Overview
  13.8.5 Beijing Balance Medical Latest Developments
13.9 Bluesail Medical
  13.9.1 Bluesail Medical Company Information
  13.9.2 Bluesail Medical Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.9.3 Bluesail Medical Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Bluesail Medical Main Business Overview
  13.9.5 Bluesail Medical Latest Developments
13.10 Shanghai HeartCare Medical
  13.10.1 Shanghai HeartCare Medical Company Information
  13.10.2 Shanghai HeartCare Medical Structural Heart Occlusion Devices Product Portfolios and Specifications
  13.10.3 Shanghai HeartCare Medical Structural Heart Occlusion Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Shanghai HeartCare Medical Main Business Overview
  13.10.5 Shanghai HeartCare Medical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Structural Heart Occlusion Devices Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Structural Heart Occlusion Devices Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Patent Ductus Arteriosis (PDA) Occluder
Table 4. Major Players of Atrial Septal Defects (ASD) Occluder
Table 5. Major Players of Ventricular Septal Defects (VSD) Occluder
Table 6. Major Players of Left Atrial Appendage ?LAA? Occluder
Table 7. Major Players of Patent Foramen Ovale (PFO) Occluder
Table 8. Global Structural Heart Occlusion Devices Sales by Type (2021-2026) & (K Units)
Table 9. Global Structural Heart Occlusion Devices Sales Market Share by Type (2021-2026)
Table 10. Global Structural Heart Occlusion Devices Revenue by Type (2021-2026) & ($ million)
Table 11. Global Structural Heart Occlusion Devices Revenue Market Share by Type (2021-2026)
Table 12. Global Structural Heart Occlusion Devices Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Structural Heart Occlusion Devices Sale by Application (2021-2026) & (K Units)
Table 14. Global Structural Heart Occlusion Devices Sale Market Share by Application (2021-2026)
Table 15. Global Structural Heart Occlusion Devices Revenue by Application (2021-2026) & ($ million)
Table 16. Global Structural Heart Occlusion Devices Revenue Market Share by Application (2021-2026)
Table 17. Global Structural Heart Occlusion Devices Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Structural Heart Occlusion Devices Sales by Company (2021-2026) & (K Units)
Table 19. Global Structural Heart Occlusion Devices Sales Market Share by Company (2021-2026)
Table 20. Global Structural Heart Occlusion Devices Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Structural Heart Occlusion Devices Revenue Market Share by Company (2021-2026)
Table 22. Global Structural Heart Occlusion Devices Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Structural Heart Occlusion Devices Producing Area Distribution and Sales Area
Table 24. Players Structural Heart Occlusion Devices Products Offered
Table 25. Structural Heart Occlusion Devices Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Structural Heart Occlusion Devices Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Structural Heart Occlusion Devices Sales Market Share Geographic Region (2021-2026)
Table 30. Global Structural Heart Occlusion Devices Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Structural Heart Occlusion Devices Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Structural Heart Occlusion Devices Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Structural Heart Occlusion Devices Sales Market Share by Country/Region (2021-2026)
Table 34. Global Structural Heart Occlusion Devices Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Structural Heart Occlusion Devices Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Structural Heart Occlusion Devices Sales by Country (2021-2026) & (K Units)
Table 37. Americas Structural Heart Occlusion Devices Sales Market Share by Country (2021-2026)
Table 38. Americas Structural Heart Occlusion Devices Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Structural Heart Occlusion Devices Sales by Type (2021-2026) & (K Units)
Table 40. Americas Structural Heart Occlusion Devices Sales by Application (2021-2026) & (K Units)
Table 41. APAC Structural Heart Occlusion Devices Sales by Region (2021-2026) & (K Units)
Table 42. APAC Structural Heart Occlusion Devices Sales Market Share by Region (2021-2026)
Table 43. APAC Structural Heart Occlusion Devices Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Structural Heart Occlusion Devices Sales by Type (2021-2026) & (K Units)
Table 45. APAC Structural Heart Occlusion Devices Sales by Application (2021-2026) & (K Units)
Table 46. Europe Structural Heart Occlusion Devices Sales by Country (2021-2026) & (K Units)
Table 47. Europe Structural Heart Occlusion Devices Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Structural Heart Occlusion Devices Sales by Type (2021-2026) & (K Units)
Table 49. Europe Structural Heart Occlusion Devices Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Structural Heart Occlusion Devices Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Structural Heart Occlusion Devices Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Structural Heart Occlusion Devices Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Structural Heart Occlusion Devices Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Structural Heart Occlusion Devices
Table 55. Key Market Challenges & Risks of Structural Heart Occlusion Devices
Table 56. Key Industry Trends of Structural Heart Occlusion Devices
Table 57. Structural Heart Occlusion Devices Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Structural Heart Occlusion Devices Distributors List
Table 60. Structural Heart Occlusion Devices Customer List
Table 61. Global Structural Heart Occlusion Devices Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Structural Heart Occlusion Devices Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Structural Heart Occlusion Devices Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Structural Heart Occlusion Devices Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Structural Heart Occlusion Devices Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Structural Heart Occlusion Devices Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Structural Heart Occlusion Devices Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Structural Heart Occlusion Devices Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Structural Heart Occlusion Devices Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Structural Heart Occlusion Devices Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Structural Heart Occlusion Devices Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Structural Heart Occlusion Devices Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Structural Heart Occlusion Devices Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Structural Heart Occlusion Devices Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Abbott Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 76. Abbott Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 77. Abbott Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Abbott Main Business
Table 79. Abbott Latest Developments
Table 80. Medtronic Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 81. Medtronic Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 82. Medtronic Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Medtronic Main Business
Table 84. Medtronic Latest Developments
Table 85. Boston Scientific Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 86. Boston Scientific Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 87. Boston Scientific Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Boston Scientific Main Business
Table 89. Boston Scientific Latest Developments
Table 90. MicroPort Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 91. MicroPort Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 92. MicroPort Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. MicroPort Main Business
Table 94. MicroPort Latest Developments
Table 95. Shenzhen Salubris Pharmaceuticals Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 96. Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 97. Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Shenzhen Salubris Pharmaceuticals Main Business
Table 99. Shenzhen Salubris Pharmaceuticals Latest Developments
Table 100. LifeTech Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 101. LifeTech Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 102. LifeTech Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. LifeTech Main Business
Table 104. LifeTech Latest Developments
Table 105. Lepu Scientech Medical Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 106. Lepu Scientech Medical Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 107. Lepu Scientech Medical Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Lepu Scientech Medical Main Business
Table 109. Lepu Scientech Medical Latest Developments
Table 110. Beijing Balance Medical Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 111. Beijing Balance Medical Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 112. Beijing Balance Medical Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Beijing Balance Medical Main Business
Table 114. Beijing Balance Medical Latest Developments
Table 115. Bluesail Medical Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 116. Bluesail Medical Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 117. Bluesail Medical Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Bluesail Medical Main Business
Table 119. Bluesail Medical Latest Developments
Table 120. Shanghai HeartCare Medical Basic Information, Structural Heart Occlusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 121. Shanghai HeartCare Medical Structural Heart Occlusion Devices Product Portfolios and Specifications
Table 122. Shanghai HeartCare Medical Structural Heart Occlusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Shanghai HeartCare Medical Main Business
Table 124. Shanghai HeartCare Medical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Structural Heart Occlusion Devices
Figure 2. Structural Heart Occlusion Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Structural Heart Occlusion Devices Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Structural Heart Occlusion Devices Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Structural Heart Occlusion Devices Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Structural Heart Occlusion Devices Sales Market Share by Country/Region (2025)
Figure 10. Structural Heart Occlusion Devices Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Patent Ductus Arteriosis (PDA) Occluder
Figure 12. Product Picture of Atrial Septal Defects (ASD) Occluder
Figure 13. Product Picture of Ventricular Septal Defects (VSD) Occluder
Figure 14. Product Picture of Left Atrial Appendage ?LAA? Occluder
Figure 15. Product Picture of Patent Foramen Ovale (PFO) Occluder
Figure 16. Global Structural Heart Occlusion Devices Sales Market Share by Type in 2026
Figure 17. Global Structural Heart Occlusion Devices Revenue Market Share by Type (2021-2026)
Figure 18. Structural Heart Occlusion Devices Consumed in Congenital Heart Disease
Figure 19. Global Structural Heart Occlusion Devices Market: Congenital Heart Disease (2021-2026) & (K Units)
Figure 20. Structural Heart Occlusion Devices Consumed in Cardioembolic Stroke
Figure 21. Global Structural Heart Occlusion Devices Market: Cardioembolic Stroke (2021-2026) & (K Units)
Figure 22. Global Structural Heart Occlusion Devices Sale Market Share by Application (2025)
Figure 23. Global Structural Heart Occlusion Devices Revenue Market Share by Application in 2026
Figure 24. Structural Heart Occlusion Devices Sales by Company in 2026 (K Units)
Figure 25. Global Structural Heart Occlusion Devices Sales Market Share by Company in 2026
Figure 26. Structural Heart Occlusion Devices Revenue by Company in 2026 ($ millions)
Figure 27. Global Structural Heart Occlusion Devices Revenue Market Share by Company in 2026
Figure 28. Global Structural Heart Occlusion Devices Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Structural Heart Occlusion Devices Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Structural Heart Occlusion Devices Sales 2021-2026 (K Units)
Figure 31. Americas Structural Heart Occlusion Devices Revenue 2021-2026 ($ millions)
Figure 32. APAC Structural Heart Occlusion Devices Sales 2021-2026 (K Units)
Figure 33. APAC Structural Heart Occlusion Devices Revenue 2021-2026 ($ millions)
Figure 34. Europe Structural Heart Occlusion Devices Sales 2021-2026 (K Units)
Figure 35. Europe Structural Heart Occlusion Devices Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Structural Heart Occlusion Devices Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Structural Heart Occlusion Devices Revenue 2021-2026 ($ millions)
Figure 38. Americas Structural Heart Occlusion Devices Sales Market Share by Country in 2026
Figure 39. Americas Structural Heart Occlusion Devices Revenue Market Share by Country (2021-2026)
Figure 40. Americas Structural Heart Occlusion Devices Sales Market Share by Type (2021-2026)
Figure 41. Americas Structural Heart Occlusion Devices Sales Market Share by Application (2021-2026)
Figure 42. United States Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Structural Heart Occlusion Devices Sales Market Share by Region in 2026
Figure 47. APAC Structural Heart Occlusion Devices Revenue Market Share by Region (2021-2026)
Figure 48. APAC Structural Heart Occlusion Devices Sales Market Share by Type (2021-2026)
Figure 49. APAC Structural Heart Occlusion Devices Sales Market Share by Application (2021-2026)
Figure 50. China Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 54. India Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Structural Heart Occlusion Devices Sales Market Share by Country in 2026
Figure 58. Europe Structural Heart Occlusion Devices Revenue Market Share by Country (2021-2026)
Figure 59. Europe Structural Heart Occlusion Devices Sales Market Share by Type (2021-2026)
Figure 60. Europe Structural Heart Occlusion Devices Sales Market Share by Application (2021-2026)
Figure 61. Germany Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 62. France Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Structural Heart Occlusion Devices Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Structural Heart Occlusion Devices Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Structural Heart Occlusion Devices Sales Market Share by Application (2021-2026)
Figure 69. Egypt Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Structural Heart Occlusion Devices Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Structural Heart Occlusion Devices in 2026
Figure 75. Manufacturing Process Analysis of Structural Heart Occlusion Devices
Figure 76. Industry Chain Structure of Structural Heart Occlusion Devices
Figure 77. Channels of Distribution
Figure 78. Global Structural Heart Occlusion Devices Sales Market Forecast by Region (2027-2032)
Figure 79. Global Structural Heart Occlusion Devices Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Structural Heart Occlusion Devices Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Structural Heart Occlusion Devices Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Structural Heart Occlusion Devices Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Structural Heart Occlusion Devices Revenue Market Share Forecast by Application (2027-2032)


More Publications